Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Assets (2016 - 2017)

Tenax Therapeutics' Assets history spans 6 years, with the latest figure at $11.0 million for Q3 2017.

  • For Q3 2017, Assets fell 81.57% year-over-year to $11.0 million; the TTM value through Sep 2017 reached $11.0 million, down 81.57%, while the annual FY2016 figure was $23.3 million, N/A changed from the prior year.
  • Assets for Q3 2017 was $11.0 million at Tenax Therapeutics, down from $13.4 million in the prior quarter.
  • Across five years, Assets topped out at $73.0 million in Q4 2015 and bottomed at $3.0 million in Q1 2013.
  • The 4-year median for Assets is $21.2 million (2016), against an average of $33.4 million.
  • The largest annual shift saw Assets plummeted 48.34% in 2013 before it crashed 81.57% in 2017.
  • A 4-year view of Assets shows it stood at $3.0 million in 2013, then soared by 2298.65% to $73.0 million in 2015, then tumbled by 68.02% to $23.3 million in 2016, then crashed by 52.86% to $11.0 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Assets are $11.0 million (Q3 2017), $13.4 million (Q2 2017), and $19.2 million (Q1 2017).